Differentiating Migraine from Other Headache Types to Target Treatment Peter J. Goadsby, MD, PhD

Similar documents
Chronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary

Headache Master School Japan-Osaka 2016 (HMSJ-Osaka2016) October 23, II. Management of Refractory Headaches

Characterising the premonitory stage of migraine in children: a clinic-based study of 100 patients in a specialist headache service

Richard B. Lipton, 1 Joel Saper, 2 Messoud Ashina, 3 David Biondi, 4 Suman Bhattacharya, 4 Joe Hirman, 5 Barbara Schaeffler, 4 Roger Cady 4

A case of a patient with chronic headache. Focus on Migraine. None related to the presentation Grants to conduct clinical trials from: Speaker bureau:

I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation.

UCNS Course A Review of ICHD-3b

Jessica Ailani MD FAHS Director, Georgetown Headache Center Associate Professor Neurology Medstar Georgetown University Hospital

Disclosures. Objectives 6/2/2017

UNDERSTANDING CHRONIC MIGRAINE. Learn about diagnosis, management, and treatment options for this headache condition

Migraine Migraine Age Specific Prevalence in the United States. Headache International Headache Society Classification

Triptans: Nonresponse, Recurrence, and Serious AEs for Many Patients

Faculty Disclosures. Learning Objectives

Joel R. Saper, 1 Richard B. Lipton, 2 David B. Kudrow, 3 Joe Hirman, 4 David W. Dodick, 5 Stephen Silberstein, 6 George Chakhava, 7 Jeff Smith 8

National Institute for Health Research, UK

Promius Pharma, a subsidiary of Dr. Reddy s Laboratories, Princeton, NJ; 2 Vedanta Research, Chapel Hill, NC; 3

Migraine Controversies in Women s Health. Professor Peter J. Goadsby 5 December Department of Neurology

6/2/2017. Objectives. Statement of Problem: Migraine Headaches Are Common. Chronic Headache In Pediatrics, Botox and Beyond

Migraine Types and Triggering Factors in Children

HEADACHE: Prevalence and Impact

Update on Diagnosis and Management of Migraines

ISSN doi: /head.13327

Headache Mary D. Hughes, MD Neuroscience Associates

Migraine much more than just a headache

Migraine Management. Roger Cady, MD Headache Care Center Springfield, MO

HEADACHES THE RED FLAGS

HEADACHES AND MIGRAINES

Headache. Karen Thaxter

MIGRAINE A MYSTERY HEADACHE

Paediatric headaches. Dr Jaycen Cruickshank Director of Clinical Training Ballarat Health Services. Brevity, levity, repetition

Headaches. Mini Medical School. November 10, A. Laine Green MSc, MD FRCP(C) Assistant Professor Department of Medicine (Neurology)

25/09/2018 HEADACHE. Dr Nick Pendleton

Disclosure. Learning Objectives 11/10/2017. The Best and Most Interesting Research from Last Year Cephalalgia

Current Migraine Treatment Therapy. Daniel Kassicieh, DO, FAAN

HEADACHE PATHOPHYSIOLOGY

Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE

HEADACHE. Dr Nick Pendleton. September Headache

By Nathan Hall Associate Editor

Research Submission. ISSN doi: /head Published by Wiley Periodicals, Inc. Headache 2013 American Headache Society

Atypical presentations of cluster headache

abstract n engl j med 377;22 nejm.org November 30,

National Hospital for Neurology and Neurosurgery. Migraine Associated Dizziness. Department of Neuro-otology

Prevalence of new daily persistent headache in the general population. The Akershus study of chronic headachecha_

HEADACHE: Types, Tips & Treatment Suggestions

HEADACHE Transient discomfort, chronic nuisance, or looming disaster?

Headache Classifica-on

10/17/2017 CHRONIC MIGRAINES BOTOX: TO INJECT OR NOT INJECT? IN CHRONIC MIGRAINE PROPHYLAXIS OBJECTIVES PATIENT CASE EPIDEMIOLOGY EPIDEMIOLOGY

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Headache Assessment In Primary Eye Care

An Overview of MOH. ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California

Trigeminal Autonomic Cephalalgias. Disclosures. Objectives 6/20/2018. Rashmi Halker Singh, MD FAHS UCNS Review Course June 2018

ARxCH. Annual Review of Changes in Healthcare. Calcitonin Gene-Related Peptide Receptors and the Prevention of Migraines. Abstract

Benign Headache and Diagnosis Pathophysiology. Dr Andrew J Dowson Director of the King s Headache Service King s College Hospital London

Diagnosing headache. The clinician should approach the diagnosis of. Secondary headache. Primary headache. Blue and red flag headaches

Cluster headache (CH): epidemiology, classification and clinical picture

Migraine: Past, Present and Future Edward O Sullivan September 12 th 2015 Dublin 12/09/2015

6/20/2018. Chronic Migraine versus Chronic Pain: Similarities and Differences. Disclosure (36 months) Clinical Differences/Background

Daniel Kassicieh, DO, FAAN

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Editorial Team Conflict of Interest Statements

Ishaq Abu Arafeh Consultant Paediatrician Royal Hospital for Children, Glasgow Forth Valley Royal Hospital, Larbert

Advances in the Treatment of Migraine

A synopsis of: Diagnosis and Management of Headaches in Adults: A national clinical guideline. Scottish intercollegiate Guidelines Network SIGN

Headache Syndrome. Karen Alvarez, D.O Nemours Children s Specialty Care Jacksonville, FL

PREVALENCE BY HEADACHE TYPE

The headache profile of idiopathic intracranial hypertension

ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา

Understanding. Migraine. Amy, diagnosed in 1989, with her family.

Tension-type Headaches

Sandler Family Trust. UCSF Medical Center. Headache A Review and Update. Headache The burden. Headache Group, UCSF Disclosure- by proportion*

Chronic Daily Headaches

Maximizing Relief: A Personalized Approach to the Acute Treatment of Migraine in an Era of New Therapeutic Delivery Mechanisms

How do we treat migraine? New SIGN Guidelines

Headache and Facial Pain. Mohammed ALEssa MBBS, FRCSC Assistant Professor Consultant Otolaryngology,Head & Neck Surgical Oncology

See Important Reminder at the end of this policy for important regulatory and legal information.

PAEDIATRIC ACUTE CARE GUIDELINE. Headache. This document should be read in conjunction with this DISCLAIMER

Primary Headache Prevalence % (95% CI) Migraine without aura 9 (7-9) Migraine with aura 6 (5-8)

Specific features of migraine syndrome in children

6/4/2018. Headache. Headaches. Headache. Migraine Headaches. Headache. Red Flag signs and symptoms. Imaging CT without contrast.

Faculty Disclosures. Learning Objectives. Acute Treatment Strategies

This policy addresses only the type B formulation rimabotulinumtoxinb marketed as Myobloc.

MIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment.

Migraine By Oliver Sacks READ ONLINE

HEADACHE HISTORY & PROFILE QUESTIONNAIRE

Understanding cluster headache

Post-Operative Cluster Headache Following Carotid Endarterectomy

OTHER PRIMARY HEADACHES: TENSION-TYPE, STABBING, HYPNIC AND NUMMULAR HEADACHE

PROGRAM SYLLABUS. Jointly provided by Potomac Center for Medical Education and Rockpointe

Migraine Management. Jane Melling Headache nurse Mater Misericordiae Hospital

DISCLOSURES FUNCTIONS OF THE HYPOTHALAMUS

Novartis announces Phase III STRIVE data published in NEJM demonstrating significant and sustained efficacy of erenumab in migraine prevention

11/10/2017. THE BRIDGE Course Objectives. THE BRIDGE Course Objectives

GENERAL APPROACH AND CLASSIFICATION OF HEADACHES

Clinical Trials. Hans-Christoph Diener Senior Professor of Clinical Neuroscienes Medical Faculty University Duisburg-Essen Germany

COMPLEXITIES OF MIGRAINE HEADACHES

EDITOR S PICK EMERGING TREATMENT OPTIONS IN MIGRAINE

Primary Care Adult Headache Management Pathway (formerly North West Headache Management Guideline for Adults) Version 1.0

Headache. Section 1. Migraine headache. Clinical presentation

Ana Podgorac Belgrade, May 2012

Do you suffer from Headaches? - November/Dec 2011

Transcription:

Differentiating Migraine from Other Headache Types to Target Treatment Peter J. Goadsby, MD, PhD University of California, San Francisco San Francisco, CA King's College London London, England

Learning 1 Objective Apply current treatment guidelines, diagnostic algorithms, and evidencebased recommendations to accurately diagnose migraine

Learning 2 Objective Improve awareness of the latest evidence for current and emerging therapies/ technologies as part of an individualized multimodal migraine management plan

Learning 3 Objective Engage the patient as an integral and active participant of treatment decisions and ongoing adherence to therapy

Peter J. Goadsby, MD, PhD Disclosures Research/Grants: Allergan; eneura Inc.; Amgen Inc. Consultant/Advisory Board: Ajinomoto Pharmaceuticals Co., Ltd.; Akita Biomedical; Alder Biopharmaceuticals Inc.; Autonomic Technologies, Inc; Avanir Pharmaceuticals, Inc.; Cipla Ltd; CoLucid Pharmaceuticals, Inc.; Dr. Reddy s Laboratories Ltd.; Eli Lilly and Company; Ethicon, US, LLC.; Heptares Therapeutics; Medical Legal Work; NuPathe, Inc.; Pfizer Inc.; Promius Pharma, LLC.; Teva Pharmaceuticals Industries Ltd.; UpToDate, Inc.; W. L. Gore & Associates, Inc.; Wells Fargo; Zosano Pharma Corporation Other Financial Interest: Dr. Goadsby has a patent Magnetic Stimulation for headache pending.

Case 1 Video to be embedded

Exploding Head Syndrome Description: Sudden feeling as though the head is exploding or of sudden noise, sometimes associated with a flash of light; in the transition between sleep and wakefulness. Described first as pistol shot or a blow to the head 1 Terms Sensory Shock 1 Snapping of the Brain 2 Exploding Head Syndrome 3 Series 4 Older age of onset Female preponderance No secondary cases 1. Mitchell, SW. Virg Med Mnthly. 1876;2(11):769-781. 2. Armstrong-Jones R. Lancet. 1920;ii:720. 3. Pearce JM. Lancet. 1988;2(8605):270-1. 4. Pearce JM. J Neurol Neurosurg Psychiatry. 1989;52(7):907-10.

Case 2 Video to be embedded

Tension-Type Headache By ICHD-3 2. Tension-type Headache A. Frequency 2.1 Infrequent: < 1 day a month 2.2 Frequent: 1-14 days a month 2.3 Chronic: >15 days a month for > 3 months B. Lasting from 2.1 & 2.2 30 minutes to 7 days 2.3 hours to days C. At least two of the following four characteristics: 1. bilateral location 2. pressing or tightening (non-pulsating) quality 3. mild or moderate intensity 4. not aggravated by routine physical activity such as walking or climbing stairs D. Both of the following: 2.1 & 2.2 1. no nausea or vomiting 2. no more than one of photophobia or phonophobia 2.3 1. no more than one of photophobia, phonophobia or mild nausea 2. neither moderate or severe nausea nor vomiting E. Not better accounted for by another ICHD-3 diagnosis.

Tension-Type Headache (appendix) A. Frequency 2.1 Infrequent: < 1 day a month 2.2 Frequent: 1-14 days a month 2.3 Chronic: >15 days a month for > 3 months B. Lasting from 2.1 & 2.2 30 minutes to 7 days 2.3 hours to days C. Three or more of 1. Bilateral 2. Pressing or tightening 3. Mild or moderate intensity 4. Not aggravated by routine physical activity D. No nausea, vomiting, photophobia or phonophobia E. Not better accounted for by another ICHD-3 diagnosis Headache Classification Committee of the International Headache Society [IHS].The International Classification of Headache Disorders. 3rd edition (beta version). International Headache Society Website. http://www.ihsclassification.org/_downloads/mixed/international-headache-classification-iii-ichd-iii-2013-beta.pdf. 2013.

Relationship of Migraine and Tension-type Headache Attacks Patient Premonitory features throbbing movement worse associations nausea photophobia phonophobia Aura Family history Triggers Sleep: missing/excess Eating: including alcohol Weather Hormonal Stress- relaxation Non-throbbing no effect of movement associations No nausea No photophobia No phonophobia? aura

Landmark Study Migraine in Primary Care Offices Prospective, open-label study Patients tracked for three months or six attacks Assigned IHS diagnoses by experts 100 80 76 Migraine Migrainous % Patients 60 40 20 0 18 Tepper SJ, et al., Headache. 2004;44(9):856-864.

Migraine The Attacks & The Disorder Attacks Premonitory symptoms Pain unilateral throbbing movement worse Nausea Sensory sensitivity photophobia phonophobia osmophobia Aura Disorder Repeated attacks < 15 days/month: Episodic 15 days/month: Chronic Family history Triggers (biology) Sleep: missing/excess Food: skipping meals Chemical: alcohol or nitroglycerin Weather Sensory: light, smells Hormonal Stress- relaxation The simple headaches have the same characters, and occur under the same causal conditions of heredity &c, as those in which there are additional other sensory symptoms Gowers WR. A manual of diseases of the nervous system. 2 nd ed. 1893.

European Case 3

Case 3 European United States

Nummular Headache Is this just one thing? 4.8 Nummular Headache Description: Pain of highly variable duration, but often chronic, in a small circumscribed area of the scalp in the absence of any underlying structural lesion. Diagnostic criteria A. Continuous or intermittent head pain fulfilling B-C B. Felt exclusively in an area of the scalp, with all of the following four characteristics: 1. sharply contoured 2. fixed in size and shape 3. round or elliptical 4. 1 6 cm in diameter, Not better accounted for by another ICHD-3 diagnosis

Case 4

Cough Headache 4.1 Cough Headache Headache precipitated by coughing or other Valsalva (straining) manoeuvre, but not by prolonged physical exercise, in the absence of any intracranial disorder. A. At least two headache episodes fulfilling criteria BD B. Brought on by and occurring only in association with coughing, straining and/or other Valsalva manoeuvre C. Sudden onset D. Lasting between 1 second and 2 hours E. Not better accounted for by another ICHD-3 Dx Raskin NH. Neurology. 1995;45(9):1784; Headache Classification Committee of the International Headache Society [IHS].The International Classification of Headache Disorders. 3rd edition (beta version). International Headache Society Website. http://www.ihs-classification.org/_downloads/mixed/international- Headache-Classification-III-ICHD-III-2013-Beta.pdf. 2013.

Cough Headache* Generalised, sudden onset headache with Valsalva manoeuvre that lasts for several minutes 1 Differential diagnosis 2 - Primary: Older, shorter (<30 min) - Secondary: Chiari, CSF pathway obstruction, cerebrovascular disease Treatment - Lumbar puncture 1,3 - Indomethacin, methysergide 4 * There are no treatments approved for cough headache by the US FDA 1. Symonds C. Brain. 1956;79(4):557-68. 2. Pascual J. Neurology. 1996;46(6):1520-4. 3. Raskin NH. Neurology. 1995;45(9):1784. 4. Bahra A, Goadsby PJ. Cephalalgia. 1998;18(7):495-6.

Review of Treatment Episodic versus Chronic Abortive Medications Prophylactic Medications Non-medication approaches Emerging treatments CGRP 5HT 1F Others Transcranial Magnetic Stimulation

Questions & Answers